pharmaphorum
OCTOBER 1, 2021
The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. The pharma company’s senior vice president for major markets talks about the continued evolution of the industry’s approach to communications and commercialisation.
Pharmaceutical Technology
JUNE 15, 2023
The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 6, 2022
HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.
PharmaKinnex
APRIL 28, 2022
Over the past few years, rare disease drugs have seen an increase in research and development from the big pharmaceutical companies. The above factors can yield higher sales, making rare disease drug development extremely lucrative and desirable. The power of inside sales begins here.
Viseven
NOVEMBER 9, 2022
Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. It’s a quantitative way to locate physicians leaders who influence the medical community.
pharmaphorum
MAY 27, 2022
The standard operating procedures that guided practice for a generation were ripped up by the pandemic and the challenges for pharmaceutic company field force teams multiplied while the opportunities diminished. Good communication is a hallmark of business success.”. About the interviewees. He graduated from UNSW, with a B.A
Pharmaceutical Technology
JULY 18, 2022
With the ever-rising costs of bringing a drug to market, pharmaceutical companies are increasingly looking at how they can improve the efficiency of their entire product development and drug commercialisation process. There is a risk for variation between batches.”.
Expert insights. Personalized for you.
52 
Let's personalize your content